// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Healthcare utilisation in chronic cough

Peter Siu Pan Cho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

N/A

The majority of patients that suffer an asthma attack at the Emergency Room (ER are mild asthmatics

Zafeiria Barmparessou - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

“I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff

Shauna McKibben - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Negotiating identity: impact on self-management practices in people with asthma and limited health literacy in Malaysia

Hani Syahida Salim - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Identification of important respiratory research themes relevant to primary care: qualitative analysis of round 1 of the 2020 International Primary Care Respiratory Group (IPCRG Research Prioritisation Exercise

Arwa Abdel-Aal - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Evidence-implementation gaps in low- and middle-income countries' COPD guidelines

Aizhamal Tabyshova - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

COPD integrated disease management, from controlled trial to real-world primary care; a cohort study

Anna Hussey - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Primary care management of asthma in Malaysia: findings of the Klang Asthma Cohort Study

Norita Hussein - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

What motivates primary healthcare practitioners to refer patients with Chronic Obstructive Pulmonary Disease (COPD to Pulmonary Rehabilitation? A survey using the Theoretical Domains Framework

Jane Watson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Methodological insights from pre-pilot phases of two complex respiratory interventions (IMP2ART; TANDEM

Elizabeth Steed - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Tackling COPD misdiagnosis in primary care through integrated care

Ketan Patel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Exploring the provision of supportive care for patients with severe, life-limiting COPD in Malaysia

Su May Liew - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Non-participant observation of medical screening for Malaysian Hajj pilgrims with asthma

Ahmad Ihsan Abu Bakar - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Respiratory Improvement programme: COPD reviews in Primary Care by Physician Associates

Sarah Sibley - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Chronic cough in routine clinical practice: a UK retrospective cohort study

James H. Hull - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long-term condition (LTC review templates in clinical consultations: A mixed-methods systematic review

Kirstie McClatchey - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Major global discrepancies in guidelines for sore throat (acute pharyngitis

Graca Coutinho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Rheumatic heart disease

N/A

Challenges in conducting community surveys on chronic respiratory diseases in Low and Middle-Income Countries: the 4CCORD pilot

Ee Ming Khoo - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study

Shamil Haroon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Severe asthma risk persists in London children

Mark L. Levy - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved